Pfizer
Founded in 1849 and headquartered in New York, Pfizer is a global biopharmaceutical company developing vaccines and therapies in oncology, rare disease, and internal medicine.
Pfizer is a research-based biopharmaceutical company founded in 1849 and headquartered in New York, with operations spanning worldwide markets. Its technical work centers on biopharmaceutical research and development: vaccine development, oncology therapeutics, rare disease therapeutics, and internal medicine therapeutics. The company states over 175 years of scientific innovation, having evolved from a small family-owned business into a global pharmaceutical organization with a broad, diversified product portfolio.
The engineering-relevant surface area covers several distinct domains. Vaccines work spans development and portfolio maintenance for prevention of infectious diseases; oncology and rare disease programs focus on advancing targeted therapies; and the internal medicine portfolio represents a diversified product line. Beyond therapeutic development, the healthcare access domain includes PfizerForAll™, an initiative providing integrated access to healthcare information and resources.
Pfizer describes its operating culture around collaborative problem-solving and bold thinking in service of delivering medicines to patients, with a stated commitment to patient care that extends beyond medicine itself. Roles are situated within a global organization whose scale - worldwide operations and a large portfolio across vaccines, oncology, rare diseases, and internal medicine - means engineering work is carried out against the constraints of regulated pharmaceutical development and global distribution.